Rates of TIMI major bleeding were higher with ticagrelor ( @ % with @ mg and @ % with @ mg ) than with placebo ( @ % ) ( P < @ for each dose vs. placebo ) ; the rates of intracranial hemorrhage or fatal bleeding in the three groups were @ % , @ % , and @ % , respectively .